ArticleInternational journal of obstetric anesthesia2026
Morbidity associated with fresh frozen plasma administration for postpartum hemorrhage requiring transfusion: a retrospective cohort study (2016-2024).
Article in International journal of obstetric anesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundRecommendations for fresh frozen plasma transfusion in postpartum hemorrhage are inconsistent and empiric administration may carry more risk than benefit. We characterized fresh frozen plasma use for postpartum hemorrhage with normal international normliazed ratio (INR) and associated adverse outcomes.
methodsPatients with postpartum hemorrhage (quantitavie blood loss ≥1000 mL) and INR ≤1.5 who received transfusion of any blood product during their delivery admission in a large tertiary academic center between 2016 and 2024 were identified. Those who received fresh frozen plasma were compared to those who did not.
resultsAmong 54,041 deliveries during the study period, 3,827 (7.1%) had a diagnosis of postpartum hemorrhage of which 530 (0.98%) were transfused. Among these, 489/530 (92%) had an INR ≤1.5, yet 37% received fresh frozen plasma. First fresh frozen plasma was frequently transfused prior to INR availability (62.8%). After adjusting for significant covariates, patients transfused with fresh frozen plasma had higher odds of composite adverse outcomes, admission to intensive care unit, and prolonged length of stay.
conclusionDespite coagulopathy being uncommon during postpartum hemorrhage, fresh frozen plasma is often administered empirically in patients with normal INR and is associated with increased risk of adverse outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.